Exenatide: pharmacokinetics, clinical use, and future directions ...
Product Monograph Template - Standard]
AstraZeneca Launches the New Bydureon Pen in the US | diaTribe
Dosing with BYDUREON® (exenatide extended-release) injectable ...
Bydureon, INN-exenatide
Bydureon Single Dose Trays to Be Discontinued - Endocrinology Advisor
Dosing with BYDUREON® (exenatide extended-release) injectable ...
PhactMI BYDUREON® (exenatide extended release)
Formulations and storage conditions for GLP-1 RA products ...
Type 2 Diabetes Drug Bydureon Gets a Makeover - GoodRx
Bydureon Auto-Injector May Boost the Drug's Sales in Future Years ...
SPECIAL FEATURE - Injection Devices: Manufacturers Focus on 21st ...
Bydureon 2 mg powder and solvent for prolonged-release suspension ...
Update on GLP-1 Agonists in Type 2 Diabetes is supported by an ...
PhactMI BYDUREON® BCise™ (exenatide extended-release)
Bydureon 2 mg powder and solvent for prolonged-release suspension ...
FDA Approves Bydureon BCise – New Autoinjector to Launch Early ...
Select your BYDUREON® (exenatide extended-release) injectable ...
SPECIAL FEATURE - Injection Devices: Manufacturers Focus on 21st ...
A Review of the Long-Term Efficacy, Tolerability, and Safety of ...
Exenatide: pharmacokinetics, clinical use, and future directions
Battle of GLP-1 delivery technologies☆ Advanced Drug Delivery Reviews
AZN - Page 3 of 7
209210Orig1s000
